0028

Asymchem Laboratories Tian Jin Co Ltd

002821.SHE asymchem.com.cn + Research + Basket
ISIN CNE100002BZ6
Employees 10,617
Phone 86 22 6638 9560
Fiscal year end December
Address No. 71, Seventh Avenue, Tianjin, China, 300457
150.24
-4.79 (-3.09%)
CNY · SHE
52-week range
87.70
200.00
Trading at 56% of the 52-week range
Market Cap
56.11B
P/E Ratio
46.42
Forward P/E
0.00
Book Value
48.73
Div. Yield
0.81%
% Institutions
23.46%
% Insiders
40.92%

1 Year

+58.8%

3 Year

+6.3%

10 Year

+940.0%
Description

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.

Actions

Add an action for 002821.SHE, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Hao Hong Ph.D. Founder, Chairman & CEO 1956
Ms. Rui Yang Co-CEO & Executive Director 1977
Mr. Da Zhang CFO, COO, Senior VP & Executive Director 1981
Mr. Jiang Yingwei Executive Vice President of Human Resources & Administration 1977
Dr. Liang Hong Executive VP & Executive Director 1974
Mr. Chaoyong Chen Executive Vice President of Manufacturing & Tech Transfer 1982
Dr. Yan Zhou Senior Vice President of Quality Management 1979
Dr. Chen Yi Cheng CTO of the Small-Molecule Sector 1964
Mr. Xiangke Xu Senior Vice President and Board Secretary of Public Affairs & Regulatory Affairs & Legal Affairs 1979
Mo Huang Accounting Supervisor NA

Financial Highlights

▼
Market Cap: $56.11B
EBITDA: $1.88B
P/E Ratio: $46.42
Book Value: $48.73
Dividend/Share: $1.30
Dividend Yield: 0.81%
Earnings/Share: $3.34
Profit Margin: 15.93%
Operating Margin: 19.10%
ROA (TTM): 4.05%
ROE (TTM): 6.70%
Revenue (TTM): $7.44B
Revenue/Share (TTM): $21.01
Earnings Growth (YOY): 81.90%
Revenue Growth (YOY): 24.00%

Valuation Metrics

Enterprise Value: $48.88B
Trailing P/E: 46.42
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 334.11M
Shares Float: 223.45M
% Insiders: 40.92%
% Institutions: 23.46%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$6.67B
Cost of Goods Sold
adjust
$-3.87B
Gross Profit
subtotal
$2.80B
SG&A
adjust
$-260.93M
R&D
adjust
$-593.26M
Other Operating Expense
adjust
$-4.56B
Operating Income
subtotal
$1.25B
Other / Non-Operating Items
adjust
$-121.54M
Net Income
subtotal
$1.13B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 002821.SHE!